Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):139–147. doi: 10.1097/PAI.0b013e31825d73b2

Table 3.

Multivariate Cox Proportional Hazard Model for 10-Year Disease-Free Survival (DFS) using 1D5 or SP1 to determine ER Status

ER Status determined by 1D5 n = 225 ER Status determined by SP1 n = 225

Characteristic HR 95% CI P HR 95% CI P
Age at diagnosis, years
 <50 vs.≥50 0.990 0.607–1.615 0.9676 0.976 0.597–1.595 0.9220
Nodal status
 Positive vs. negative 0.481 0.308–0.752 0.0013 0.475 0.303–0.744 0.0012
Tumor size, mm
 ≤2 vs. ≥5 0.287 0.160–0.516 < 0.0001 0.308 0.171–0.556 < 0.0001
 2–5 vs. ≥5 0.483 0.292–0.799 0.0046 0.488 0.294–0.810 0.0055
Nuclear Grade
 1 vs. 3 0.855 0.430–1.700 0.6547 0.887 0.441–1.783 0.7365
 2 vs. 3 0.983 0.617–1.564 0.9413 0.963 0.603–1.538 0.8745
ER status
 Positive vs. negative 1.943 1.230–3.069 0.0044 1.994 1.220–3.259 0.0059

Overall model is significant with 1D5 (Chi-Square = 44.169, Wald P-value = <0.0001) and with SP1 (Chi-Square = 44.319, Wald P-value = <0.0001). ER, estrogen receptor; HR, adjusted hazard ratio; DFS, disease-free survival